Search research articles
Contact Us
Filters
Showing results (31-40 of 35) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 35 results.
ESMO Open
|
May 13, 2021
Breast cancer patients treated with intrathecal therapy for leptomeningeal metastases in a large real-life database
M Carausu, M Carton, A Darlix, et al.
Gynecologic Oncology
|
March 6, 2020
The French national network dedicated to rare gynecological cancers diagnosis and management could improve the quality of surgery in daily practice of granulosa cell tumors. A TMRG and GINECO group Study
C Lenck, N Chopin, S Gouy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 21, 2023
Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial
I Ray-Coquard, A Leary, S Pignata, et al.
Gynecologic Oncology
|
July 7, 2020
Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network
F Derquin, A Floquet, A C Hardy-Bessard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 5, 2017
Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study
H Bourgeois, F Grudé, P Solal-Céligny, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 35) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 35 results.
ESMO Open
|
May 13, 2021
Breast cancer patients treated with intrathecal therapy for leptomeningeal metastases in a large real-life database
M Carausu, M Carton, A Darlix, et al.
Gynecologic Oncology
|
March 6, 2020
The French national network dedicated to rare gynecological cancers diagnosis and management could improve the quality of surgery in daily practice of granulosa cell tumors. A TMRG and GINECO group Study
C Lenck, N Chopin, S Gouy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 21, 2023
Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial
I Ray-Coquard, A Leary, S Pignata, et al.
Gynecologic Oncology
|
July 7, 2020
Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network
F Derquin, A Floquet, A C Hardy-Bessard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 5, 2017
Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study
H Bourgeois, F Grudé, P Solal-Céligny, et al.
Page
of 4